BIOLARGO, INC. Stockholders Equity

Quick Answer

BIOLARGO, INC. reported Stockholders Equity of $4.04 million for the year ending 2025.

  • BIOLARGO, INC. showed a decrease of -54.3% in Stockholders Equity from 2024 to 2025.
  • This data is from BIOLARGO, INC.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
  • XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2011: -$2.30 million | Q1 2012: -$1.75 million | Q2 2012: -$938.2 thousand | Q3 2012: -$1.05 million | Q2 2013: -$574.5 thousand | Q3 2013: -$363.3 thousand | Q1 2014: -$23.9 thousand | Q2 2014: -$54.8 thousand | Q3 2014: -$325.8 thousand | Q1 2015: -$413.7 thousand | Q2 2015: -$485.2 thousand | Q3 2015: $257.2 thousand | Q1 2016: $217.6 thousand | Q1 2017: -$2.11 million | Q2 2017: -$3.75 million | Q3 2017: -$3.09 million | Q1 2018: -$5.20 million | Q2 2018: -$1.14 million | Q3 2018: -$1.36 million | Q1 2019: -$2.08 million | Q2 2019: -$2.13 million | Q3 2019: -$1.12 million | Q1 2020: -$2.73 million | Q2 2020: $2.64 million | Q3 2020: $4.68 million | Q1 2021: $4.75 million | Q2 2021: $5.06 million | Q3 2021: $4.81 million | Q1 2022: $4.49 million | Q2 2022: $4.47 million | Q3 2022: $4.96 million | Q1 2023: $6.39 million | Q2 2023: $7.37 million | Q3 2023: $7.07 million | Q1 2024: $8.12 million | Q2 2024: $6.00 million | Q3 2024: $8.58 million | Q1 2025: $7.61 million | Q2 2025: $8.76 million | Q3 2025: $6.58 million.
  • Over the full 17 years of available data (2009 to 2025), BIOLARGO, INC.'s Stockholders Equity has grown by 204.6%.
  • Historical annual values: Fiscal year 2025: $4.04 million | Fiscal year 2024: $8.85 million | Fiscal year 2023: $6.84 million | Fiscal year 2022: $4.88 million | Fiscal year 2021: $4.65 million | Fiscal year 2020: $3.86 million | Fiscal year 2019: -$2.15 million | Fiscal year 2018: -$1.50 million | Fiscal year 2017: -$4.10 million | Fiscal year 2016: -$1.33 million | Fiscal year 2015: $351.8 thousand | Fiscal year 2014: -$392.3 thousand | Fiscal year 2013: -$565.0 thousand | Fiscal year 2012: -$289.7 thousand | Fiscal year 2011: -$1.52 million | Fiscal year 2010: -$2.59 million | Fiscal year 2009: -$3.86 million.
  • Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: